Pages that link to "Q37024362"
Jump to navigation
Jump to search
The following pages link to Modulation of death receptors by cancer therapeutic agents (Q37024362):
Displaying 50 items.
- Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling (Q24296451) (← links)
- A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB (Q24635114) (← links)
- Molecular targets of TRAIL-sensitizing agents in colorectal cancer (Q26822382) (← links)
- Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway (Q28394743) (← links)
- Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis (Q28474952) (← links)
- Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer (Q33563815) (← links)
- Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer (Q33658593) (← links)
- The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation (Q33762403) (← links)
- Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo (Q33914440) (← links)
- ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1 (Q34438717) (← links)
- Understanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer Metastasis (Q34731599) (← links)
- Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia (Q34992476) (← links)
- Combination of TRAIL with bortezomib shifted apoptotic signaling from DR4 to DR5 death receptor by selective internalization and degradation of DR4. (Q35327231) (← links)
- DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells (Q35536334) (← links)
- The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells (Q35613406) (← links)
- The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition (Q35884130) (← links)
- (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice (Q36561629) (← links)
- Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling. (Q36562365) (← links)
- (E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5). (Q36681789) (← links)
- Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B (Q36688998) (← links)
- PPARgamma and Apoptosis in Cancer (Q36742811) (← links)
- Growth Inhibitory Effect of (E)-2,4-bis(p-hydroxyphenyl)-2-Butenal Diacetate through Induction of Apoptotic Cell Death by Increasing DR3 Expression in Human Lung Cancer Cells (Q37145431) (← links)
- Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells (Q37295559) (← links)
- Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation. (Q37330410) (← links)
- Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications (Q37512907) (← links)
- Tumor Necrosis Factor-related apoptosis-inducing ligand (TRAIL) Receptor-1 and Receptor-2 agonists for cancer therapy (Q37621564) (← links)
- Enhanced Anti-Cancer Effect of Snake Venom Activated NK Cells on Lung Cancer Cells by Inactivation of NF-κB (Q37684206) (← links)
- Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). (Q38673432) (← links)
- Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition (Q38748966) (← links)
- Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells. (Q38836957) (← links)
- Application of bee venom and its main constituent melittin for cancer treatment (Q38966140) (← links)
- Myriocin induces apoptotic lung cancer cell death via activation of DR4 pathway (Q39036953) (← links)
- Co-culture with NK-92MI cells enhanced the anti-cancer effect of bee venom on NSCLC cells by inactivation of NF-κB. (Q39038239) (← links)
- The PI3 kinase inhibitor NVP-BKM120 induces GSK3/FBXW7-dependent Mcl-1 degradation, contributing to induction of apoptosis and enhancement of TRAIL-induced apoptosis (Q39170414) (← links)
- mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis (Q39210322) (← links)
- Induction of apoptosis in human Hep3B hepatoma cells by norcantharidin through a p53 independent pathway via TRAIL/DR5 signal transduction (Q39287935) (← links)
- Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells (Q39454078) (← links)
- Retinoic acid enhances TRAIL-induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expression (Q39521964) (← links)
- Bcl-xL Is a Dominant Antiapoptotic Protein that Inhibits Homoharringtonine-Induced Apoptosis in Leukemia Cells (Q39574450) (← links)
- Role of elevated pressure in TRAIL-induced apoptosis in human lung carcinoma cells (Q39681559) (← links)
- c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589. (Q39707590) (← links)
- Isoangustone A present in hexane/ethanol extract of Glycyrrhiza uralensis induces apoptosis in DU145 human prostate cancer cells via the activation of DR4 and intrinsic apoptosis pathway (Q39727718) (← links)
- Interferon-gamma bolsters CD95/Fas-mediated apoptosis of astroglioma cells. (Q39801663) (← links)
- In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by taxol (Q41967143) (← links)
- Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance. (Q42042886) (← links)
- DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion (Q42283261) (← links)
- Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer (Q45872444) (← links)
- Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts. (Q46603509) (← links)
- IgG-single-chain TRAIL fusion proteins for tumour therapy. (Q54998541) (← links)
- Death receptor 6 is epigenetically silenced by histone deacetylation in endometriosis and promotes the pathogenesis of endometriosis. (Q55057370) (← links)